These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6577946)

  • 21. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
    Schwartz EL; Sartorelli AC
    Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinobenzoic acids. 6. Retinoid antagonists with a heterocyclic ring.
    Eyrolles L; Kagechika H; Kawachi E; Fukasawa H; Iijima T; Matsushima Y; Hashimoto Y; Shudo K
    J Med Chem; 1994 May; 37(10):1508-17. PubMed ID: 8182710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-activity relationships of methylene or terminal side chain modified retinoids on the differentiation and cell death signaling in NB4 promyelocytic leukemia cells.
    Ivanova D; Rossin A; Gronemeyer H; Valla A; Cartier D; Le Guillou R; Labia R
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4257-61. PubMed ID: 15261282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Studies on retinoids. IV. Design, synthesis and structure-activity relationships of di-t-butylphenyl compounds].
    Guo ZR; Liu QZ; Chu FM; Wang MM; Pi SQ; Yang GZ; Han R; Xia LJ; He XQ
    Yao Xue Xue Bao; 1997 Nov; 32(11):830-43. PubMed ID: 11596202
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benzodithiophenes induce differentiation and apoptosis in human leukemia cells.
    Jing Y; Hellinger N; Xia L; Monks A; Sausville EA; Zelent A; Waxman S
    Cancer Res; 2005 Sep; 65(17):7847-55. PubMed ID: 16140954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinobenzoic acids. 4. Conformation of aromatic amides with retinoidal activity. Importance of trans-amide structure for the activity.
    Kagechika H; Himi T; Kawachi E; Shudo K
    J Med Chem; 1989 Oct; 32(10):2292-6. PubMed ID: 2795600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinoids as preventive and therapeutic anticancer agents (Part I).
    Lippman SM; Kessler JF; Meyskens FL
    Cancer Treat Rep; 1987 Apr; 71(4):391-405. PubMed ID: 3548957
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The growth-supporting activity of a retinoidal benzoic acid derivative and 4,4-difluororetinoic acid.
    Stephens-Jarnagin A; Miller DA; DeLuca HF
    Arch Biochem Biophys; 1985 Feb; 237(1):11-6. PubMed ID: 3970539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
    Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
    Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and characterization of retinoic acid receptor beta2 target genes in F9 teratocarcinoma cells.
    Zhuang Y; Faria TN; Chambon P; Gudas LJ
    Mol Cancer Res; 2003 Jun; 1(8):619-30. PubMed ID: 12805409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation induction of human promyelocytic leukemia cells by acyclic retinoid (polyprenoic acid).
    Tsurumi H; Tojo A; Takahashi T; Ozawa K; Moriwaki H; Asano S; Muto Y
    Int J Hematol; 1993 Dec; 59(1):9-15. PubMed ID: 8161738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indeno[1,2-c]isoquinolines as enhancing agents on all-trans retinoic acid-mediated differentiation of human myeloid leukemia cells.
    Kim SH; Oh SM; Song JH; Cho D; Le QM; Lee SH; Cho WJ; Kim TS
    Bioorg Med Chem; 2008 Feb; 16(3):1125-32. PubMed ID: 18024133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Receptor-related mechanism of proliferation inhibilion and apoptosis induetion of human tongue squamous cell line Tca8113 by retinoids].
    Niu XW; Feng J; Peng ZH; Ma HQ; Liu C; Yuan JY
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Aug; 25(8):935-41. PubMed ID: 16109544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of CD95 in leukemia and lymphoma cells by retinoids.
    Munker R; Koeffler P; Haas R; Wilmanns W
    Eur J Med Res; 2000 Jun; 5(6):273-6. PubMed ID: 10882644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of mammary tumorigenesis in transgenic mice by the RXR-selective retinoid, LGD1069.
    Wu K; Kim HT; Rodriquez JL; Hilsenbeck SG; Mohsin SK; Xu XC; Lamph WW; Kuhn JG; Green JE; Brown PH
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):467-74. PubMed ID: 12010861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different combinations of retinoids and vitamin D3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines.
    Defacque H; Dornand J; Commes T; Cabane S; Sevilla C; Marti J
    J Pharmacol Exp Ther; 1994 Oct; 271(1):193-9. PubMed ID: 7965714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.